FDA Inspection 955661 — PD-Rx Pharmaceuticals, Inc.

PD-Rx Pharmaceuticals, Inc. — FEI 1641825

The FDA completed an inspection of PD-Rx Pharmaceuticals, Inc. on Dec 4, 2015 in Oklahoma City, OK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 4, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Oklahoma City, OK (United States)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
117721 CFR 211.63Equipment Design, Size and Location
154021 CFR 211.125(a)Strict control not exercised over labeling issued
191421 CFR 211.166(a)Lack of written stability program
200721 CFR 211.186(a)Signature and checking of records -- 2 persons
241921 CFR 211.198(a)Complaint Handling Procedure

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.